The OCTSI has new resources to help you complete the NIH Human Subjects Section. This includes brief instructions for every section, links to key external resources, and samples that investigators can download and modify. These resources, created by the OSCTR Science Writing Unit, are available
The Oklahoma Clinical and Translational Science Institute (OCTSI) and Oklahoma Shared Clinical and Translational Resources (OSCTR) is soliciting applications for its Clinical and Translational Research Pilot (CTRP) Grants Program.
The Oklahoma Clinical and Translational Science Institute (OCTSI) is soliciting applications for opioid-related research pilot grants funded through its Oklahoma Shared Clinical and Translational Resources (OSCTR) Pilot Grants Program.
The OSCTR Clinical Research Toolkit site is currently in beta development, but we wanted to make it available to users to help facilitate researchers. We also welcome suggestions from users about features and information you would find helpful on the site. Over the next few months, we will be adding additional information to each category.
The site can be reached through the toolbar on the left of the page or at http://octsi.ouhsc.edu/toolkit.
OSCTR-OUHSC PROFILES RESEARCH NETWORKING SOFTWARE IS NOW FUNCTIONAL
The OCTSI has partnered with the OUHSC Department of Pediatrics and been awarded a grant from the National Institutes of Health to develop the Oklahoma Pediatric Clinical Trial Network. This network will be part of the IDeA States Pediatric Clinical Trials Network that is participating in the Environmental Impacts of Child Health Outcomes (ECHO) Program to effectively investigate the impacts of environmental exposures from the womb through later years in a child’s life. The Principal Investigator of this award is Dr. Paul Darden, Chief of General and Community Pediatrics at OUHSC.
Heart disease remains the number one cause of death in the United States, claiming more lives than all cancers combined. Heart disease is also taking a toll on Oklahoma. But the evidence is clear—we can reduce the threat by applying the ABCS of cardiovascular disease prevention: Aspirin use by high-risk individuals, Blood pressure control, Cholesterol management, and Smoking cessation.
OCAST Oklahoma Innovations will air this Saturday and Sunday on the stations below. It will be available on the OCAST website www.ok.gov/ocast/News_Media/Radio_Show , along with a transcript, on Monday.
Researchers with the University of Oklahoma in Tulsa and Oklahoma City have received a $15 million grant to improve heart health in residents throughout the state.
Nobel Laureate to speak at OSCTR Grand Rounds event
Dr. Peter Agre, 2003 Nobel Laureate in Chemistry, will present on "Opening Doors Worldwide through Medical Science" at 12 PM, May 1, 2015 at the Samis Center.